Current Immunotherapeutic Approaches in Pancreatic Cancer

被引:69
|
作者
Koido, Shigeo [1 ,2 ,3 ]
Homma, Sadamu [3 ]
Takahara, Akitaka [1 ]
Namiki, Yoshihisa [2 ]
Tsukinaga, Shintaro [1 ]
Mitobe, Jimi [1 ]
Odahara, Shunichi [1 ]
Yukawa, Toyokazu [1 ]
Matsudaira, Hiroshi [1 ]
Nagatsuma, Keisuke [1 ]
Uchiyama, Kan [1 ]
Satoh, Kenichi [1 ]
Ito, Masaki [3 ]
Komita, Hideo [1 ]
Arakawa, Hiroshi [1 ]
Ohkusa, Toshifumi [1 ,2 ]
Gong, Jianlin [4 ]
Tajiri, Hisao [1 ]
机构
[1] Jikei Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo 1058461, Japan
[2] Jikei Univ, Sch Med, Inst Clin Med & Res, Tokyo 1058461, Japan
[3] Jikei Univ, Sch Med, Dept Oncol, Inst DNA Med, Tokyo 1058461, Japan
[4] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA
关键词
GROWTH-FACTOR RECEPTOR; COLONY-STIMULATING FACTOR; CYTOTOXIC T-LYMPHOCYTES; PHASE-III TRIAL; PERSONALIZED PEPTIDE VACCINATION; UNIVERSAL TUMOR-ANTIGEN; CELL-BASED VACCINATION; HUMAN DENDRITIC CELLS; PLUS GEMCITABINE; CARCINOMA CELLS;
D O I
10.1155/2011/267539
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pancreatic cancer is a highly aggressive and notoriously difficult to treat. As the vast majority of patients are diagnosed at advanced stage of the disease, only a small population is curative by surgical resection. Although gemcitabine-based chemotherapy is typically offered as standard of care, most patients do not survive longer than 6 months. Thus, new therapeutic approaches are needed. Pancreatic cancer cells that develop gemcitabine resistance would still be suitable targets for immunotherapy. Therefore, one promising treatment approach may be immunotherapy that is designed to target pancreatic-cancer-associated antigens. In this paper, we detail recent work in immunotherapy and the advances in concept of combination therapy of immunotherapy and chemotherapy. We offer our perspective on how to increase the clinical efficacy of immunotherapies for pancreatic cancer.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Current and future immunotherapeutic approaches in Hodgkin lymphoma
    Broeckelmann, Paul J.
    Borchmann, Peter
    Engert, Andreas
    LEUKEMIA & LYMPHOMA, 2016, 57 (09) : 2014 - 2024
  • [22] Immunotherapeutic approaches for the treatment of breast cancer
    Knutson, KL
    Schiffman, K
    Rinn, K
    Disis, ML
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 1999, 4 (04) : 353 - 365
  • [23] Immunotherapeutic Approaches for the Treatment of Breast Cancer
    Keith L. Knutson
    Kathy Schiffman
    Kristine Rinn
    Mary L. Disis
    Journal of Mammary Gland Biology and Neoplasia, 1999, 4 : 353 - 365
  • [24] Immunotherapeutic Approaches for the Treatment of Colorectal Cancer
    Abakushina, E. V.
    Gelm, Yu. V.
    Pasova, I. A.
    Bazhin, A. V.
    BIOCHEMISTRY-MOSCOW, 2019, 84 (07) : 720 - 728
  • [25] New immunotherapeutic approaches for cancer treatment
    Kamrani, Amin
    Hosseinzadeh, Ramin
    Shomali, Navid
    Heris, Javad Ahmadian
    Shahabi, Parviz
    Mohammadinasab, Reza
    Sadeghvand, Shahram
    Ghahremanzadeh, Kazem
    Sadeghi, Mohammadreza
    Akbari, Morteza
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 248
  • [26] Immunotherapeutic Approaches for the Treatment of Colorectal Cancer
    E. V. Abakushina
    Yu. V. Gelm
    I. A. Pasova
    A. V. Bazhin
    Biochemistry (Moscow), 2019, 84 : 720 - 728
  • [27] Novel immunotherapeutic approaches in gastric cancer
    Yang, Meng
    Lin, Wuhao
    Huang, Jiaqian
    Mannucci, Alessandro
    Luo, Huiyan
    PRECISION CLINICAL MEDICINE, 2024, 7 (04)
  • [28] Immunotherapeutic approaches to ovarian cancer treatment
    Chester, Cariad
    Dorigo, Oliver
    Berek, Jonathan S.
    Kohrt, Holbrook
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2015, 3
  • [29] Novel immunotherapeutic approaches to prostate cancer
    Dalgleish, A
    Whelan, M
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2005, 7 (01) : 30 - 34
  • [30] Current Approaches to the Management of Locally Advanced Pancreatic Cancer
    Malinosky, Hannah R. R.
    Stewart, John H. H.
    Moaven, Omeed
    CURRENT SURGERY REPORTS, 2023, 11 (10) : 260 - 269